These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2100586)

  • 21. Separation and quantitation of (R)- and (S)-atenolol in human plasma and urine using an alpha 1-AGP column.
    Enquist M; Hermansson J
    Chirality; 1989; 1(3):209-15. PubMed ID: 2642050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A micromethod for the quantification of atenolol in plasma using high-performance liquid chromatography with fluorescence detection: therapeutic drug monitoring of two patients with severe coronary insufficiency before cardiac surgery.
    Leite Fda S; Pereira VA; Omosako CE; Carmona MJ; Auler JO; Santos SR
    Ther Drug Monit; 2006 Apr; 28(2):237-44. PubMed ID: 16628137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct enantiospecific HPLC bioanalysis of (R,S)-atenolol on a chiral stationary phase.
    Kofahl B; Henke D; Mutschler E
    Chirality; 1993; 5(6):479-82. PubMed ID: 8398605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electron-capture-gas chromatographic determination of atenolol in plasma and urine, using a simplified procedure with improved selectivity.
    Ervik M; Kylberg-Hanssen K; Lagerström PO
    J Chromatogr; 1980 Jun; 182(3-4):341-7. PubMed ID: 7391176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of serum atenolol using HPLC with fluorescence detection following isolation with activated charcoal.
    Alebić-Kolbah T; Plavsić F; Wolf-Coporda A
    J Pharm Biomed Anal; 1989; 7(12):1777-81. PubMed ID: 2490566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stereoselective release of (S)-atenolol from adrenergic nerve endings at exercise.
    Stoschitzky K; Lindner W; Klein W
    Lancet; 1992 Sep; 340(8821):696-7. PubMed ID: 1355800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct injection analysis of atenolol enantiomers in plasma using an achiral/chiral coupled column HPLC system.
    He J; Shibukawa A; Nakagawa T; Wada H; Fujima H; Imai E; Go-oh Y
    Chem Pharm Bull (Tokyo); 1993 Mar; 41(3):544-8. PubMed ID: 8477506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of exercise on renal clearance of atenolol.
    Mason WD; Kochak G; Winer N; Cohen I
    J Pharm Sci; 1980 Mar; 69(3):344-5. PubMed ID: 7381717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitive LC-MS/MS-ESI method for simultaneous determination of nifedipine and atenolol in human plasma and its application to a human pharmacokinetic study.
    Kallem RR; Inamadugu JK; Ramesh M; Seshagirirao JV
    Biomed Chromatogr; 2013 Mar; 27(3):349-55. PubMed ID: 22886904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Semi-automated 96-well liquid-liquid extraction for quantitation of drugs in biological fluids.
    Zhang N; Hoffman KL; Li W; Rossi DT
    J Pharm Biomed Anal; 2000 Feb; 22(1):131-8. PubMed ID: 10727132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of the new beta-blocker bisoprolol and of metoprolol, atenolol and propranolol in plasma and urine by high-performance liquid chromatography.
    Bühring KU; Garbe A
    J Chromatogr; 1986 Oct; 382():215-24. PubMed ID: 2878004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous estimation of amlodipine and atenolol in human plasma: a sensitive LC-MS/MS method validation and its application to a clinical PK study.
    Kallem RR; Mullangi R; Hotha KK; Ravindranath LK; Spoorthy YN; Seshagirirao JV
    Bioanalysis; 2013 Apr; 5(7):827-37. PubMed ID: 23534427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorimetric determination of atenolol in plasma and urine by direct evaluation of thin-layer chromatograms.
    Schäfer M; Mutschler E
    J Chromatogr; 1979 Feb; 169():477-81. PubMed ID: 536437
    [No Abstract]   [Full Text] [Related]  

  • 34. Hydrophilic interaction liquid chromatographic tandem mass spectrometric determination of atenolol in human plasma.
    Li W; Li Y; Francisco DT; Naidong W
    Biomed Chromatogr; 2005 Jun; 19(5):385-93. PubMed ID: 15651086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral bioavailability of atenolol.
    Vergin H; Nitsche V
    J Int Med Res; 1989; 17(5):417-25. PubMed ID: 2806714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A highly sensitive LC-MS/MS method capable of simultaneously quantitating celiprolol and atenolol in human plasma for a cassette cold-microdosing study.
    Minamide Y; Osawa Y; Nishida H; Igarashi H; Kudoh S
    J Sep Sci; 2011 Jul; 34(13):1590-8. PubMed ID: 21595025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aiming for steady 24-hour plasma concentrations: a comparison of two calcium antagonist and beta-blocker combinations.
    Eriksson M; Nyberg G; Lidman K; Olofsson B; Bergstrand R
    Blood Press Suppl; 1993; 1():16-21. PubMed ID: 7909705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Determination in biologic media of a new beta-blocker, atenolol, by high performance liquid chromatography].
    Decourt S; Flouvat B
    J Chromatogr; 1979 Jun; 174(1):258-63. PubMed ID: 546890
    [No Abstract]   [Full Text] [Related]  

  • 39. Determination of the beta-blocker atenolol in plasma by capillary zone electrophoresis.
    Arias R; Jiménez RM; Alonso RM; Télez M; Arrieta I; Flores P; Ortiz-Lastra E
    J Chromatogr A; 2001 May; 916(1-2):297-304. PubMed ID: 11382304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a MSFIA sample treatment system as front end of GC-MS for atenolol and propranolol determination in human plasma.
    Brunetto Mdel R; Clavijo S; Delgado Y; Orozco W; Gallignani M; Ayala C; Cerdà V
    Talanta; 2015 Jan; 132():15-22. PubMed ID: 25476273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.